CNS Pharmaceuticals News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at CNS Pharmaceuticals

• Rami Levin, Chief Executive Officer and Director
• George Gumulka, Independent Director
• Bettina Cockroft, Independent Director

Popular executive movements at CNS Pharmaceuticals

• Dylan Wenke has joined the company as Chief Business Officer  (posted on March 4 2026).
• Sandra Silberman, Chief Medical Officer, has left the company  (posted on March 4 2026).
• Steve O'Loughlin has joined the company as Chief Financial Officer  (posted on March 4 2026).

Click here to view some more movements at CNS Pharmaceuticals

Create your alert
to follow the executive moves at CNS Pharmaceuticals.

CNS Pharmaceuticals has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by CNS Pharmaceuticals

• Press Releases | CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• View more press releases Close

Social media about CNS Pharmaceuticals

• CNS Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• CNS Pharmaceuticals on LinkedIn, X (Twitter) & YouTube